352 related articles for article (PubMed ID: 31454891)
1.
Vega BA; Belinka BA; Kachlany SC
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
[No Abstract] [Full Text] [Related]
2. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
[TBL] [Abstract][Full Text] [Related]
3. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes.
Kaur M; Kachlany SC
Microbiology (Reading); 2014 Nov; 160(Pt 11):2443-2452. PubMed ID: 25169107
[TBL] [Abstract][Full Text] [Related]
4. Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.
Brown AC; Boesze-Battaglia K; Balashova NV; Mas Gómez N; Speicher K; Tang HY; Duszyk ME; Lally ET
PLoS One; 2018; 13(10):e0205871. PubMed ID: 30335797
[TBL] [Abstract][Full Text] [Related]
5. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin.
Dileepan T; Kachlany SC; Balashova NV; Patel J; Maheswaran SK
Infect Immun; 2007 Oct; 75(10):4851-6. PubMed ID: 17635865
[TBL] [Abstract][Full Text] [Related]
6. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.
Balashova N; Dhingra A; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):106-14. PubMed ID: 26361372
[TBL] [Abstract][Full Text] [Related]
7. Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.
Nygren P; Balashova N; Brown AC; Kieba I; Dhingra A; Boesze-Battaglia K; Lally ET
Cell Microbiol; 2019 Mar; 21(3):e12967. PubMed ID: 30329215
[TBL] [Abstract][Full Text] [Related]
8. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
[TBL] [Abstract][Full Text] [Related]
9. Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.
DiFranco KM; Gupta A; Galusha LE; Perez J; Nguyen TK; Fineza CD; Kachlany SC
J Biol Chem; 2012 May; 287(21):17618-17627. PubMed ID: 22467872
[TBL] [Abstract][Full Text] [Related]
10. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
Krueger E; Brown AC
Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
[TBL] [Abstract][Full Text] [Related]
11. Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells.
Dietmann A; Millonig A; Combes V; Couraud PO; Kachlany SC; Grau GE
Microb Pathog; 2013; 61-62():43-50. PubMed ID: 23665198
[TBL] [Abstract][Full Text] [Related]
12. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
Kachlany SC
J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
[TBL] [Abstract][Full Text] [Related]
13.
Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
[TBL] [Abstract][Full Text] [Related]
14. Receptor-Based Peptides for Inhibition of Leukotoxin Activity.
Krueger E; Hayes S; Chang EH; Yutuc S; Brown AC
ACS Infect Dis; 2018 Jul; 4(7):1073-1081. PubMed ID: 29742342
[TBL] [Abstract][Full Text] [Related]
15. The Extracellular Domain of the β
Ristow LC; Tran V; Schwartz KJ; Pankratz L; Mehle A; Sauer JD; Welch RA
mBio; 2019 Jul; 10(4):. PubMed ID: 31289186
[TBL] [Abstract][Full Text] [Related]
16. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.
Johansson A
Toxins (Basel); 2011 Mar; 3(3):242-59. PubMed ID: 22069708
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.
Forman MS; Nishikubo JB; Han RK; Le A; Balashova NV; Kachlany SC
Toxins (Basel); 2010 Dec; 2(12):2824-36. PubMed ID: 22069577
[TBL] [Abstract][Full Text] [Related]
18. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.
Balashova NV; Park DH; Patel JK; Figurski DH; Kachlany SC
Infect Immun; 2007 Sep; 75(9):4490-7. PubMed ID: 17635874
[TBL] [Abstract][Full Text] [Related]
19. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.
Brown AC; Balashova NV; Epand RM; Epand RF; Bragin A; Kachlany SC; Walters MJ; Du Y; Boesze-Battaglia K; Lally ET
J Biol Chem; 2013 Aug; 288(32):23607-21. PubMed ID: 23792963
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
